Masato Noguchi

Dr. Masato Noguchi

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KTKazuhiko Tatemoto
Kazuhiko Tatemoto
YNYuko Nozaki
Yuko Nozaki
RTRyoko Tsuda
Ryoko Tsuda
SKShinobu Konno
Shinobu Konno
KTKeiko Tomura
Keiko Tomura
TNTakayuki Naito
Takayuki Naito

1 February 1997 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MMMichael J. Mendez
Michael J. Mendez
LGLarry L. Green
Larry L. Green
JCJose R.F. Corvalan
Jose R.F. Corvalan
XJXiao-Chi Jia
Xiao-Chi Jia
CMCatherine E. Maynard-Currie
Catherine E. Maynard-Currie
AJAya Jakobovits
Aya Jakobovits

1 May 1994 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
LGL.L. Green
L.L. Green
MHM.C. Hardy
M.C. Hardy
CMC.E. Maynard-Currie
C.E. Maynard-Currie
HTH. Tsuda
H. Tsuda
DLD.M. Louie
D.M. Louie
AJA. Jakobovits
A. Jakobovits

27 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
HOHiroyuki Ogasawara
Hiroyuki Ogasawara
MNMasato Noguchi
Masato Noguchi
Mast cells (MCs) act as primary effectors in inflammatory and allergic reactions by releasing intracellularly-stored inflammatory mediators in diseases. The two major pathways for MC activation are known to be immunoglobulin E (IgE)-dependent and -independent. Although IgE-dependent signaling is the main pathway to MC activation, IgE-independent pathways have also been found to serve pivotal roles in the pathophysiology of various inflammatory conditions. Recent studies have shown that human and mouse MCs express several regulatory receptors such as toll-like receptors (TLRs), CD48, C300a, and GPCRs, including mas-related GPCR-X2 (MRGPRX2). MRGPRX2 has been reported as a novel GPCR that is expressed in MCs activated by basic secretagogues, neurokinin peptides, host defense antimicrobial peptides, and small molecule compounds (e.g., neuromuscular blocking agents) and leads to MC degranulation and eicosanoids release under in vitro experimental condition. Functional analyses of MRGPRX2 and Mrgprb2 (mouse ortholog) indicate that MRGPRX2 is involved in MC hypersensitivity reactions causing neuroinflammation such as postoperative pain, type 2 inflammation, non-histaminergic itch, and drug-induced anaphylactic-like reactions. In this review, we discuss the roles in innate immunity through functional studies on MRGPRX2-mediated IgE-independent MC activation and also the therapeutic potential of MRGPRX2 inhibitors on allergic and inflammatory diseases.

12 July 2019 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
HOHiroyuki Ogasawara
Hiroyuki Ogasawara
MFMasahiro Furuno
Masahiro Furuno
KEKoji Edamura
Koji Edamura
MNMasato Noguchi
Masato Noguchi

9 November 2015 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
KHKazuyuki Hirata
Kazuyuki Hirata
MKMasayuki Kotoku
Masayuki Kotoku
NSNoriyoshi Seki
Noriyoshi Seki
TMTakaki Maeba
Takaki Maeba
KMKatsuya Maeda
Katsuya Maeda
MSMakoto Shiozaki
Makoto Shiozaki